Temasek Holdings (Private) LTD Bio N Tech Se Transaction History
Temasek Holdings (Private) LTD
- $20 Billion
- Q4 2024
A detailed history of Temasek Holdings (Private) LTD transactions in Bio N Tech Se stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 1,807,232 shares of BNTX stock, worth $183 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
1,807,232
Previous 1,807,232
-0.0%
Holding current value
$183 Million
Previous $215 Million
4.06%
% of portfolio
1.03%
Previous 0.88%
Shares
8 transactions
Others Institutions Holding BNTX
# of Institutions
358Shares Held
39.3MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.16MShares$825 Million0.67% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$434 Million0.39% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$431 Million1.71% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$192 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA1.42MShares$143 Million0.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...